Pomalidomide + Low-Dose Dexamethasone + Daratumumab in Relapsed and/or Refractory Multiple Myeloma after Lenalidomide-Based Treatment Failure
暂无分享，去创建一个
D. Siegel | D. Reece | A. Agarwal | G. Schiller | M. Sebag | N. Bahlis | C. Seet | K. Song | J. Matous | B. Anz | S. Ganguly | C. Samaras | G. Talamo | J. Berdeja | F. Zafar | D. Quick | M. Bar | M. Acosta-Rivera | Weiyuan Chung | G. Fonseca